Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation
Abstract Levels of secretory phospholipases A2 (sPLA2) highly increase under acute and chronic inflammatory conditions. sPLA2 is mainly associated with high-density lipoproteins (HDL) and generates bioactive lysophospholipids implicated in acute and chronic inflammatory processes. Unexpectedly, phar...
Guardado en:
Autores principales: | Sanja Curcic, Michael Holzer, Lisa Pasterk, Eva Knuplez, Thomas O. Eichmann, Saša Frank, Robert Zimmermann, Rudolf Schicho, Akos Heinemann, Gunther Marsche |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48d7c4c6f75c4565921dcb6695e9d898 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
2-Oxoesters: A Novel Class of Potent and Selective Inhibitors of Cytosolic Group IVA Phospholipase A2
por: Maroula G. Kokotou, et al.
Publicado: (2017) -
Association of proportion of the HDL-cholesterol subclasses HDL-2b and HDL-3 and macrovascular events among patients undergoing hemodialysis
por: Wen-Chin Lee, et al.
Publicado: (2021) -
The Role of PGE2 in Alveolar Epithelial and Lung Microvascular Endothelial Crosstalk
por: Thomas Bärnthaler, et al.
Publicado: (2017) -
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Mengdie Luo, et al.
Publicado: (2017) -
Assessing HDL Metabolism in Subjects with Elevated Levels of HDL Cholesterol and Coronary Artery Disease
por: William Hancock-Cerutti, et al.
Publicado: (2021)